Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Humoral Response to Pneumococcal Vaccines in RA Patients Treated With Abatacept
NCT02547493Completed
- Sponsor
- CHU Montpellier
- Start
- Mar 2016
- Primary completion
- Jan 2021
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
Randomised, open-label trial of pneumococcal 13-valent conjugate vaccine in pneumococcal infection (2 arms), sponsored by CHU Montpellier. Primary endpoint: Humoral response comparison after vaccination at 1 month. Started Mar 2016; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02547493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02547493.